GlassScriptPhysician profile
Nicholas Pelz
NPI 1518607779
$8,619.74
in general payments reported to CMS, 2019-2025
13 companies · $7,416 in 2025
The $7,416 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $247 · 2024: $957 · 2025: $7,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,445 · Travel and Lodging: $3,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,445.20 |
| Travel and Lodging | $3,927.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,316.99 | 2024-2025 | Persona, Avenir, G7 |
| Stryker Corporation | $448.40 | 2024-2025 | Mako, Pangea, Accolade |
| Si-Bone, INC. | $318.41 | 2024-2025 | |
| Polynovo North America LLC | $296.27 | 2024-2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $226.51 | 2024-2025 | Na, Fibergraft Bg Morsels, Motoband Cp |
| Axogen | $201.68 | 2025 | |
| Boston Scientific Corporation | $143.10 | 2025 | Wavewriter Alpha Prime 16 |
| Microport Orthopedics INC | $140.57 | 2024 | Mpo Medial Pivot Knee |
| Innovation Technologies INC | $139.88 | 2025 | Irrisept |
| Abbott Laboratories | $127.28 | 2024 | Eterna |
| Avanos Medical | $126.12 | 2022 | |
| Smith+Nephew, INC. | $120.96 | 2022 | |
| Cosa Medical, LLC | $13.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Pelz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.